NONCOMPACT- International Consortium for Multimodality Phenotyping in Adults with Non-compaction

Brief description of study

This is a prospective, multicenter observational study to identify clinical, genetic and imaging predictors of clinical outcome in patients with suspected non-compaction cardiomyopathy

Many healthy people have increased trabeculations without consequences, however, some may develop blood clots, heart rhythm disorders or heart failure later in life. Currently we cannot predict who will develop these problems, and therefore we do not know which people with increased trabeculations would benefit from treatment to prevent these problems.

The purpose of this research study is to use imaging tests combined with genetics to identify patients with increased trabeculations who are at increased risk and might benefit from preventive measures. In this research study we will collect clinical information through questionnaires and from your charts. We will also use your echocardiogram and MRI scans for additional analyses to discover new characteristics and patterns.

Finally, we will collect the results of genetic test that may have been performed. These imaging tests and genetic tests have been performed as part of your clinical management, or some of the tests will be performed in the near future.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
cardiomyopathy
Age: Between 18 Years - 99 Years
Gender: All

Inclusion criteria: • Above 18 years of age • Hypertrabeculation of the left ventricle fulfilling the echo-based Jenni criteria of NCCM24 • Cardiac MRI examination performed or planned for clinical purposes

Exclusion criteria (Aim 1): • Complex congenital disease, neuromuscular disorders or isolated RV non-compaction • Inability to provide informed consent

Exclusion criteria to the cardiac CT exam (Aim 2): • Age less than 21 years • Decompensated heart failure, or otherwise clinically unstable • BMI>40 kg/m2 • Pregnancy (cannot be ruled out) • Known contrast medium allergy • Kidney dysfunction: eGFR<45 ml/min

• Thyroid disease: toxic multinodular goiter, Graves’ disease, Hashimoto’s thyroiditis

Updated on 09 Mar 2024. Study ID: 842984

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).